Muriel C. Maurer - Publications

University of Louisville, Louisville, KY, United States 

36 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Mouapi KN, Wagner LJ, Stephens CA, Hindi MM, Wilkey DW, Merchant ML, Maurer MC. Evaluating the Effects of Fibrinogen αC Mutations on the Ability of Factor XIII to Crosslink the Reactive αC Glutamines (Q237, Q328, Q366). Thrombosis and Haemostasis. PMID 31055797 DOI: 10.1055/S-0039-1687875  0.72
2019 Billur R, Sabo TM, Maurer MC. Thrombin Exosite Maturation and Ligand Binding at ABE II Help Stabilize PAR-Binding Competent Conformation at ABE I. Biochemistry. PMID 30672691 DOI: 10.1021/Acs.Biochem.8B00943  0.72
2017 Billur R, Ban D, Sabo TM, Maurer MC. Deciphering Conformational Changes Associated with the Maturation of Thrombin Anion Binding Exosite I. Biochemistry. PMID 29111672 DOI: 10.1021/Acs.Biochem.7B00970  0.72
2017 Jadhav MA, Goldsberry WN, Zink SE, Lamb KN, Simmons KE, Riposo CM, Anokhin BA, Maurer MC. Screening Cleavage of Factor XIII V34X Activation Peptides by Thrombin Mutants: A Strategy for Controlling Fibrin Architecture. Biochimica Et Biophysica Acta. PMID 28687225 DOI: 10.1016/J.Bbapap.2017.07.001  0.64
2016 Mouapi KN, Bell JD, Smith KA, Ariëns RA, Philippou H, Maurer MC. Ranking reactive glutamines in the fibrinogen αC region that are targeted by blood coagulant Factor XIII. Blood. PMID 26951791 DOI: 10.1182/Blood-2015-09-672303  0.72
2014 Doiphode PG, Malovichko MV, Mouapi KN, Maurer MC. Evaluating factor XIII specificity for glutamine-containing substrates using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry assay. Analytical Biochemistry. 457: 74-84. PMID 24751466 DOI: 10.1016/J.Ab.2014.04.014  1
2013 Malovichko MV, Sabo TM, Maurer MC. Ligand binding to anion-binding exosites regulates conformational properties of thrombin. The Journal of Biological Chemistry. 288: 8667-78. PMID 23378535 DOI: 10.1074/Jbc.M112.410829  1
2012 Maurer MC. Liberating R169 promotes anticoagulant protein C. Blood. 120: 501-2. PMID 22822000 DOI: 10.1182/Blood-2012-05-427401  1
2011 Jadhav MA, Lucas RC, Goldsberry WN, Maurer MC. Design of Factor XIII V34X activation peptides to control ability to interact with thrombin mutants. Biochimica Et Biophysica Acta. 1814: 1955-63. PMID 21798378 DOI: 10.1016/J.Bbapap.2011.07.012  1
2011 Woofter RT, Maurer MC. Role of calcium in the conformational dynamics of factor XIII activation examined by hydrogen-deuterium exchange coupled with MALDI-TOF MS. Archives of Biochemistry and Biophysics. 512: 87-95. PMID 21640701 DOI: 10.1016/J.Abb.2011.05.009  1
2011 Maurer MC. Switching cation-binding loops paves the way for redesigning allosteric activation. Proceedings of the National Academy of Sciences of the United States of America. 108: 5145-6. PMID 21415371 DOI: 10.1073/Pnas.1102132108  1
2010 Jadhav MA, Isetti G, Trumbo TA, Maurer MC. Effects of introducing fibrinogen Aalpha character into the factor XIII activation peptide segment. Biochemistry. 49: 2918-24. PMID 20218626 DOI: 10.1021/Bi902127U  1
2009 Cleary DB, Doiphode PG, Sabo TM, Maurer MC. A non-reactive glutamine residue of alpha2-antiplasmin promotes interactions with the factor XIII active site region. Journal of Thrombosis and Haemostasis : Jth. 7: 1947-9. PMID 19691486 DOI: 10.1111/J.1538-7836.2009.03583.X  1
2009 Sabo TM, Maurer MC. Biophysical investigation of GpIbalpha binding to thrombin anion binding exosite II. Biochemistry. 48: 7110-22. PMID 19591434 DOI: 10.1021/Bi900745B  1
2007 Sabo TM, Brasher PB, Maurer MC. Perturbations in factor XIII resulting from activation and inhibition examined by solution based methods and detected by MALDI-TOF MS. Biochemistry. 46: 10089-101. PMID 17691819 DOI: 10.1021/Bi700579Z  1
2007 Isetti G, Maurer MC. Employing mutants to study thrombin residues responsible for factor XIII activation peptide recognition: a kinetic study. Biochemistry. 46: 2444-52. PMID 17286389 DOI: 10.1021/Bi0622120  1
2006 Cleary DB, Maurer MC. Characterizing the specificity of activated Factor XIII for glutamine-containing substrate peptides. Biochimica Et Biophysica Acta. 1764: 1207-17. PMID 16820332 DOI: 10.1016/J.Bbapap.2006.05.003  1
2006 Sabo TM, Farrell DH, Maurer MC. Conformational analysis of gamma' peptide (410-427) interactions with thrombin anion binding exosite II. Biochemistry. 45: 7434-45. PMID 16768439 DOI: 10.1021/Bi060360K  1
2006 Maurer MC, Trumbo TA, Isetti G, Turner BT. Probing interactions between the coagulants thrombin, Factor XIII, and fibrin(ogen). Archives of Biochemistry and Biophysics. 445: 36-45. PMID 16364233 DOI: 10.1016/J.Abb.2005.11.009  1
2004 Turner BT, Sabo TM, Wilding D, Maurer MC. Mapping of factor XIII solvent accessibility as a function of activation state using chemical modification methods. Biochemistry. 43: 9755-65. PMID 15274630 DOI: 10.1021/Bi049260+  1
2004 Isetti G, Maurer MC. Thrombin activity is unaltered by N-terminal truncation of factor XIII activation peptides. Biochemistry. 43: 4150-9. PMID 15065858 DOI: 10.1021/Bi049796V  1
2004 Isetti G, Maurer MC. Probing thrombin's ability to accommodate a V34F substitution within the factor XIII activation peptide segment (28-41). The Journal of Peptide Research : Official Journal of the American Peptide Society. 63: 241-52. PMID 15049836 DOI: 10.1111/J.1399-3011.2004.00132.X  1
2003 Trumbo TA, Maurer MC. V34I and V34A substitutions within the factor XIII activation peptide segment (28-41) affect interactions with the thrombin active site. Thrombosis and Haemostasis. 89: 647-53. PMID 12669118 DOI: 10.1055/S-0037-1613570  1
2003 Cleary DB, Ehringer WD, Maurer MC. Establishing the inhibitory effects of bradykinin on thrombin. Archives of Biochemistry and Biophysics. 410: 96-106. PMID 12559981 DOI: 10.1016/S0003-9861(02)00677-X  1
2002 Marinescu A, Cleary DB, Littlefield TR, Maurer MC. Structural features associated with the binding of glutamine-containing peptides to Factor XIII. Archives of Biochemistry and Biophysics. 406: 9-20. PMID 12234485 DOI: 10.1016/S0003-9861(02)00407-1  1
2002 Cleary DB, Trumbo TA, Maurer MC. Protease-activated receptor 4-like peptides bind to thrombin through an optimized interaction with the enzyme active site surface. Archives of Biochemistry and Biophysics. 403: 179-88. PMID 12139967 DOI: 10.1016/S0003-9861(02)00220-5  1
2002 Turner BT, Maurer MC. Evaluating the roles of thrombin and calcium in the activation of coagulation factor XIII using H/D exchange and MALDI-TOF MS. Biochemistry. 41: 7947-54. PMID 12069584 DOI: 10.1021/Bi025630N  1
2002 Trumbo TA, Maurer MC. Thrombin hydrolysis of V29F and V34L mutants of factor XIII (28-41) reveals roles of the P(9) and P(4) positions in factor XIII activation. Biochemistry. 41: 2859-68. PMID 11851434 DOI: 10.1021/Bi0157823  1
2000 Trumbo TA, Maurer MC. Examining thrombin hydrolysis of the Factor XIII activation peptide segment leads to a proposal for explaining the cardioprotective effects observed with the Factor XIII V34L mutation Journal of Biological Chemistry. 275: 20627-20631. PMID 10801785 DOI: 10.1074/Jbc.M000209200  1
1999 Maurer MC, Trosset JY, Lester CC, DiBella EE, Scheraga HA. New general approach for determining the solution structure of a ligand bound weakly to a receptor: structure of a fibrinogen Aalpha-like peptide bound to thrombin (S195A) obtained using NOE distance constraints and an ECEPP/3 flexible docking program. Proteins. 34: 29-48. PMID 10336381 DOI: 10.1002/(Sici)1097-0134(19990101)34:1<29::Aid-Prot4>3.0.Co;2-U  1
1998 Maurer MC, Peng JL, An SS, Trosset JY, Henschen-Edman A, Scheraga HA. Structural examination of the influence of phosphorylation on the binding of fibrinopeptide A to bovine thrombin. Biochemistry. 37: 5888-902. PMID 9558322 DOI: 10.1021/Bi972538W  1
1995 DiBella EE, Maurer MC, Scheraga HA. Expression and folding of recombinant bovine prethrombin-2 and its activation to thrombin. The Journal of Biological Chemistry. 270: 163-9. PMID 7814368 DOI: 10.1074/Jbc.270.1.163  1
1992 Maurer MC, Sando JJ, Grisham CM. High-affinity Ca(2+)- and substrate-binding sites on protein kinase C alpha as determined by nuclear magnetic resonance spectroscopy. Biochemistry. 31: 7714-21. PMID 1510956  1
1992 Sando JJ, Maurer MC, Bolen EJ, Grisham CM. Role of cofactors in protein kinase C activation. Cellular Signalling. 4: 595-609. PMID 1489656 DOI: 10.1016/0898-6568(92)90041-6  1
1992 Maurer MC, Grisham CM, Sando JJ. Activation and inhibition of protein kinase C isozymes alpha and beta by Gd3+. Archives of Biochemistry and Biophysics. 298: 561-8. PMID 1416985 DOI: 10.1016/0003-9861(92)90450-B  1
1988 Gibbs EJ, Maurer MC, Zhang JH, Reiff WM, Hill DT, Malicka-Blaszkiewicz M, McKinnie RE, Liu HQ, Pasternack RF. Interactions of porphyrins with purified DNA and more highly organized structures. Journal of Inorganic Biochemistry. 32: 39-65. PMID 3346661 DOI: 10.1016/0162-0134(88)80014-X  1
Show low-probability matches.